Digital therapeutics firm Click Therapeutics will acquire the assets of Better Therapeutics, including a mobile app for Type 2 diabetes patients called AspyreRx, following approval by the FDA. The acquisition comes after Better announced the layoff of all its employees due to lack of capital reserves. Click aims to develop a digital therapeutic for obesity using the acquired assets in combination with metabolic disorder medications.
![](https://healsecurity.com/wp-content/uploads/2024/09/cdc-issues-warning-over-recalled-eggs-sold-in-three-states.jpg)
CDC issues warning over recalled eggs sold in three states
The Centers for Disease Control and Prevention (CDC) has issued a warning against recalled eggs linked to 24 hospitalizations due to salmonella infection. The eggs,